Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body Mass Index (BMI) for treatment response in a real...

Full description

Bibliographic Details
Main Authors: Alessia Manni, Antonio Iaffaldano, Giuseppe Lucisano, Mariangela D'Onghia, Domenico Maria Mezzapesa, Vincenzo Felica, Pietro Iaffaldano, Maria Trojano, Damiano Paolicelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Immunology
Subjects:
dimethyl fumarate
lymphocyte count
body mass index
biomarkers
treatment response
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01343/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01343/full

Similar Items